WOLFGANG WINKELMAYER to Factor XI
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Factor XI.
Connection Strength
0.983
-
A Phase II randomized controlled trial evaluated antithrombotic treatment with fesomersen in patients with kidney failure on hemodialysis. Kidney Int. 2024 07; 106(1):145-153.
Score: 0.934
-
Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target. Kidney Int. 2021 12; 100(6):1199-1207.
Score: 0.049